Apoptosis and tumor regression in locally advanced non-small cell lung cancer with neoadjuvant therapy;Apoptose und tumorregression bei neoadjuvant behandelten lokal fortgeschrittenen nichtkleinzelligen lungenkarzinomen

Pathologe

Volumn 24, Issue 3, 2003, Pages 214-219

  Junker, K ^a   Muller K M ^a   Bosse, U ^b   Klinke, F ^c   Heinecke, A ^d   Thomas, M ^d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Institut fur Pathologie   (Germany)

^c St Raphael Hospital   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apoptosis; Neoadjuvant therapy; Non small cell lung cancer; Therapy induced tumour regression

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR REGRESSION;

EID: 0038617413     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-002-0607-4     Document Type: Article

References (26)

1. Coates PJ, Save V, Ansari B, Hall PA (1995) Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol 176:19-26
2. Dou QP, An B, Will PL (1995) Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci U S A 92:9019-9023
3. Eastman A (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2:275-280
4. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542
5. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 192:493-501
6. Götz C, Montenarh M (1995) P53 and its implication in apoptosis (review). Int J Oncol 6:1129-1135
7. Han Z, Chatterjee D, He DM, Early J, Pantazis P, Wyche J, Hendrickson EA (1995) Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol Cell Biol 15:5849-5857
8. Hickman JA, Potten CS, Merritt AJ, Fisher TC (1994) Apoptosis and cancer chemotherapy. Philos Trans R Soc Lond B Biol Sci 345:319-325
9. Joseph B, Lewensohn R, Zhivotovsky B (2000) Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann N Y Acad Sci 926:204-216
10. Junker K (2001) Tumorregression bösartiger Lungentumoren. Akademos Wissenschaftsverlag, Hamburg
11. Junker K, Thomas M, Schulmann K, Klinke V, Bosse U, Müller KM (1997) Regressionsgrading neoadjuvant behandelter nichtkleinzelliger Lungenkarzinome. Pathologe 18:131-140
12. Junker K, Wiethege T, Müller KM, Thomas M (2000) P53 tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy. J Cancer Res Clin Oncol 126:238-245
13. Junker K, Langner K, Klinke F, Bosse U, Thomas M (2001) Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 120:1584-1591
14. Kaplan EL, Meier P (1958) Non-parametrics estimation from incomplete observations. J Am Stat Assoc 53:457-481
15. Kastan MB, Canman CE, Leonard CJ (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14:3-15
16. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
17. Lowe SW, Bodis S, McClatchey A et al. (1994) P53 status and the efficacy of cancer therapy in vivo. Science 266:807-810
18. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710-1717
19. Peto R, Pike MC, Armitage P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. analysis and examples. Br J Cancer 35:1-39
20. Solary E, Dubrez L, Eymin B (1996) The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J 9:1293-1305
21. Tanaka F, Takata T, Yamada T et al. (2002) Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer. Lung Cancer 36:27-32
22. Thomas M, Rübe C, Semik M et al. (1999) Impact of preoperative biomodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 17:1185-1193
23. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
24. Törmänen U, Eerola AK, Rainio P et al. (1995) Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55:5595-5602
25. Vermes I, Haanen C (1994) Apoptosis and programmed cell death in health and disease. Adv Clin Chem 31:177-246
26. Wyllie AH (1993) Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67:205-208